314 related articles for article (PubMed ID: 27343712)
1. Cycling hypoxia: A key feature of the tumor microenvironment.
Michiels C; Tellier C; Feron O
Biochim Biophys Acta; 2016 Aug; 1866(1):76-86. PubMed ID: 27343712
[TBL] [Abstract][Full Text] [Related]
2. Cycling hypoxia induces a specific amplified inflammatory phenotype in endothelial cells and enhances tumor-promoting inflammation in vivo.
Tellier C; Desmet D; Petit L; Finet L; Graux C; Raes M; Feron O; Michiels C
Neoplasia; 2015 Jan; 17(1):66-78. PubMed ID: 25622900
[TBL] [Abstract][Full Text] [Related]
3. The roles of reactive oxygen species and autophagy in mediating the tolerance of tumor cells to cycling hypoxia.
Koritzinsky M; Wouters BG
Semin Radiat Oncol; 2013 Oct; 23(4):252-61. PubMed ID: 24012339
[TBL] [Abstract][Full Text] [Related]
4. NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme.
Hsieh CH; Wu CP; Lee HT; Liang JA; Yu CY; Lin YJ
Free Radic Biol Med; 2012 Aug; 53(4):649-58. PubMed ID: 22713363
[TBL] [Abstract][Full Text] [Related]
5. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression.
Cosse JP; Michiels C
Anticancer Agents Med Chem; 2008 Oct; 8(7):790-7. PubMed ID: 18855580
[TBL] [Abstract][Full Text] [Related]
6. Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and metastases.
Daneau G; Boidot R; Martinive P; Feron O
Clin Cancer Res; 2010 Jan; 16(2):410-9. PubMed ID: 20068092
[TBL] [Abstract][Full Text] [Related]
7. Cycling hypoxia induces chemoresistance through the activation of reactive oxygen species-mediated B-cell lymphoma extra-long pathway in glioblastoma multiforme.
Chen WL; Wang CC; Lin YJ; Wu CP; Hsieh CH
J Transl Med; 2015 Dec; 13():389. PubMed ID: 26711814
[TBL] [Abstract][Full Text] [Related]
8. The close interaction between hypoxia-related proteins and metastasis in pancarcinomas.
López-Cortés A; Prathap L; Ortiz-Prado E; Kyriakidis NC; León Cáceres Á; Armendáriz-Castillo I; Vera-Guapi A; Yumiceba V; Simbaña-Rivera K; Echeverría-Garcés G; García-Cárdenas JM; Pérez-Villa A; Guevara-Ramírez P; Abad-Sojos A; Bautista J; Puig San Andrés L; Varela N; Guerrero S
Sci Rep; 2022 Jun; 12(1):11100. PubMed ID: 35773405
[TBL] [Abstract][Full Text] [Related]
9. Tumor and its microenvironment: a synergistic interplay.
Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661
[TBL] [Abstract][Full Text] [Related]
10. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
Joshi S; Singh AR; Zulcic M; Durden DL
Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
[TBL] [Abstract][Full Text] [Related]
11. 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways.
DelNero P; Lane M; Verbridge SS; Kwee B; Kermani P; Hempstead B; Stroock A; Fischbach C
Biomaterials; 2015 Jul; 55():110-8. PubMed ID: 25934456
[TBL] [Abstract][Full Text] [Related]
12. Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.
Scanlon SE; Glazer PM
DNA Repair (Amst); 2015 Aug; 32():180-189. PubMed ID: 25956861
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factors as key regulators of tumor inflammation.
Mamlouk S; Wielockx B
Int J Cancer; 2013 Jun; 132(12):2721-9. PubMed ID: 23055435
[TBL] [Abstract][Full Text] [Related]
14. Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment.
Lisanti MP; Martinez-Outschoorn UE; Chiavarina B; Pavlides S; Whitaker-Menezes D; Tsirigos A; Witkiewicz A; Lin Z; Balliet R; Howell A; Sotgia F
Cancer Biol Ther; 2010 Sep; 10(6):537-42. PubMed ID: 20861671
[TBL] [Abstract][Full Text] [Related]
15. The role of reactive oxygen species and metabolism on cancer cells and their microenvironment.
Costa A; Scholer-Dahirel A; Mechta-Grigoriou F
Semin Cancer Biol; 2014 Apr; 25():23-32. PubMed ID: 24406211
[TBL] [Abstract][Full Text] [Related]
16. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
17. [Vascular perfusion as the origin of neoplasm resistance to radio- and chemotherapy].
Martinive P; Coucke PA
Rev Med Liege; 2010 Mar; 65(3):133-9. PubMed ID: 20411817
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathways: emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment.
Kuonen F; Secondini C; Rüegg C
Clin Cancer Res; 2012 Oct; 18(19):5196-202. PubMed ID: 22730447
[TBL] [Abstract][Full Text] [Related]
19. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-mediated biological control.
Cassavaugh J; Lounsbury KM
J Cell Biochem; 2011 Mar; 112(3):735-44. PubMed ID: 21328446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
